Supply Chain

The FDA issued warnings against using three at-home COVID-19 tests that have not been authorized by the agency over the risk of false results. 

Several widely used rapid antigen at-home COVID-19 tests are effective at detecting omicron, according to preliminary research published Feb. 28 in MedRxiv. 

The ongoing COVID-19 pandemic and supply challenges have shown the need for contingency stock plans that allow you to continue delivering quality patient care while navigating inventory crises. This involves the three following components:

While a record-breaking 41,354 organ transplants were performed in the U.S. last year, the nation's current organ transplantation system is inequitable, and more can be done to boost that number, according to a report published Feb. 25 from the National…

A former medical supply company owner in Virginia Beach, Va., has been sentenced to 51 months in prison in connection with a multimillion dollar healthcare fraud scheme, the U.S. Justice Department said Feb. 24.

Arrow International recalled over 24,000 percutaneous thrombolytic devices due to risk of tip damage during use, which could result in tip detachment from the basket.

The Biden administration released long-term actions it plans to take to boost supply chain resiliency Feb. 24. 

Ten health systems have posted job listings for supply chain expertise in the last week: 

The FDA released a list of 17 rapid COVID-19 at-home tests Feb. 22 that are authorized by the agency.

Medtronic and the American Society for Gastrointestinal Endoscopy are partnering to provide endoscopy centers in underserved communities with AI-assisted colonoscopy tools to allow better access to colon cancer screenings.